Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 497-499.

Contributing to SDG 3 (good health and well-being) and SDG 5 (gender equality), this commentary explores if the genetics, anatomy, physiology, biochemistry, and health-care experience of women and girls remain under-addressed in the health sciences.
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Page 493.

Contributing to SDGs 3 (good health and well-being), 5 (gender equality) and 16 (peace, justice and strong institutions), this editorial piece discusses the need for men, researchers, clinicians, institutional leaders and medical journals to improve gender equity and support feminism within the fields of science, medicine and global health.
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 21-22.

This correspondence discusses Singapore's success in progressing towards SDG 3 (good health and well-being) and SDG 5 (gender equality).
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 27-28.

This correspondence discusses the ways in which Sweden's feminist foreign policy could be applied to governments across the world in efforts to improve SDG 3 (global health and well-being) and SDG 5 (gender equality).
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 560-569.

Directly contributing to SDG 3 (good health and well-being), SDG 5 (gender equality) and SDG 8 (decent work and economic growth), this review promotes why gender equality in science, medicine and global health matters for health and health-related outcomes.
Elsevier,

The Lancet Volume 393, Issue 10171, 9–15 February 2019, Pages 521-523.

Relating to SDG 5 (gender equality) and SDG 3 (good health and well-being), this correspondence discusses global negative health affects on women and children as a consequence of gender disparity in global health leadership.
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 25-26.

This correspondence explores the importance of women within global health care and the opportunity to produce win-win gender-transformative dividends across the Sustainable Development Goals, in particular SDG 3 (good health and well-being), SDG 5 (gender equality) and SDG 8 (decent work and economic growth).
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Page 511.

This commentary expresses the urgent need for the inclusion of SDG 5 (gender equality) within global health communities. Ending discrimination against women and girls is essential to achieve SDG 3 (good health and well-being).
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 550-559.

Contributing to Sustainable Development Goals 3 (good health and well-being), 5 (gender equality), 8 (decent work and economic growth) and 10 (reduced inequalities), this research identifies the importance of diversification and gender equity in the scientific workforce and in the research populations to produce effective medical research.
Elsevier,

The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 601-603.

Directly relevant to SDGs 5 (gender equality), 3 (good health and well-being) and 8 (decent work and economic growth), this viewpoint proposes four critical recommendations to achieve women's representation and gender-inclusive practices across every level of science, medicine and global health.

Pages